Vypin has been issued patent number 9,904,885 by the United States Patent Office. The Patent, “Wireless Medication Compliance Sensing Device, System and Related Methods” addresses the World Health Organization medication adherence as defined as “the degree to which the person’s behavior corresponds with the agreed recommendations from a healthcare provider.” Failure of patients to take the prescribed medications leads to substantial worsening of disease, and in some cases death. The patient not taking their medication when and how prescribed leads to increase health care cost. This Vypin patent helps physicians, pharmacists and nurses have a significant role in their daily practice to improve patient medication adherence.
Robert Sengstaken, CTO & Mitch Bernet, CEO
According to AARP, six out of 10 patients do not take their medications as prescribed by their physicians. Hospitalizations related to non-adherence cost the U.S. health care system $100 billion to $289 billion a year.
The patented Vypin system augments blister packs with printed wireless sensors that update Cloud-based records regarding patient interaction with their medicines. A primary application is unit dose packaging for blister packs. Unit dose packaging alone has been shown to be a first step toward increasing compliance.
Robert Sengstaken, CTO, and Patent Inventor states: “This Vypin patent can help the patient, physician and family of the patient, ensure that the medications are taken as prescribed, not skipping doses or taking the medication at incorrect times or doses. The consequence of non-adherence is a waste of medication, quality of life, increase use in medical resources such as nursing homes, hospital visits, and hospital admissions. Helping people take their medication as prescribed will avoid a higher risk of severe relapses, resistance to drugs like antibiotics and reduce preventable hospitalizations.”
This Wireless Medication Compliance Sensing Device will be most helpful for chronic diseases, as estimates of medications non-adherence are greatest when patients are symptom-free. Non-adherence can also occur when the doses or regimen is complex- resulting in the improper administration of one or more drugs or at unusual times during the course of the medication. This Vypin device will help the patient with the deviations in taking medication or omission of doses or delay of the timing of doses. Additionally, the Vypin blister pack provides: refill coordination, dosage error notification, and notifications to family or support team of compliance.
Mitch Bernet, Vypin CEO states, ” We are improving patient outcomes, advancing medication adherence and reducing hospital re-admissions with this IoT blister pack. The notifications can be sent to the patient families or caregivers to provide social support, as tactics that impede patient noncompliance is usually occurring due to regimens that require a fundamental modification of the patient’s daily life, or because time and opportunity to counsel parties may be brief they may have misunderstood the importance of taking their medication as prescribed. Vypin understands that compliance is ultimately a motivational issue, we help the patient follow their medication therapies. This encourages the patient to feel like part of the solution rather than the problem”